Warren Buffett’s investment strategy emphasizes caution when others are greedy and opportunity when they are fearful. As of Wednesday, shares of Dr. Reddy’s Laboratories Ltd. (Symbol: RDY) have entered oversold territory with a Relative Strength Index (RSI) of 24.5, indicating potential opportunities for bullish investors. The stock price reached a low of $11.365 per share, compared to the S&P 500 ETF (SPY) RSI of 48.7.
Dr. Reddy’s 52-week performance shows a low of $11.36 and a high of $15.67, with the last trade recorded at $11.38, suggesting that significant selling pressure may be easing.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
